Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03900468 · ClinicalTrials.gov registry record · NA

Medtronic Deep Brain Stimulation (DBS) Therapy for Epilepsy Post-Approval Study (EPAS)

A NA study of Epilepsy, sponsored by MedtronicNeuro.

Active
Registry status
NA
Development phase
140
Enrollment target
13
Study locations

NCT03900468 is a NA study of Epilepsy that is active but no longer recruiting, run by MedtronicNeuro. The registered enrollment target is 140 participants, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (85% lower). The trial reports 13 study locations across 10 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03900468, a NA study of Epilepsy, is active but no longer recruiting, sponsored by MedtronicNeuro.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
140 participants
Enrollment target
13
Study locations

Study Summary

The purpose of this post-approval study is to further evaluate the long-term safety and effectiveness of Medtronic DBS therapy for epilepsy on seizure reduction in newly implanted participants through 3 years of follow-up.

Conditions Studied

Epilepsy

Interventions

  • DEVICE Activa™ PC and Percept™ PC Neurostimulation Systems

Study Locations (13)

California

  • University of California Los Angeles (UCLA) - Los Angeles
  • University of California San Francisco UCSF Medical Center - San Francisco
  • Stanford Hospital & Clinics - Stanford

Ohio

  • Cleveland Clinic - Cleveland
  • The Ohio State University - Columbus

Georgia

  • Emory University Hospital - Atlanta

Illinois

  • Rush University Medical Center - Chicago

Indiana

  • Indiana University Health Neuroscience Center - Indianapolis

Kansas

  • University of Kansas Medical Center - Kansas City

Massachusetts

  • Massachusetts General Hospital - Boston

Minnesota

  • Mayo Clinic (Rochester MN) - Rochester

Trial Details

FieldValue
Enrollment Target 140 participants
Start Date 2020-03-05
Est. Completion 2026-03-27
Phase NA

Sponsor

MedtronicNeuro

51 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03900468

The ClinicalTrials.gov registry entry for NCT03900468 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (85% lower). The listed sponsor is MedtronicNeuro, which has 51 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Epilepsy appearing as the primary indexed condition, and to 1 intervention - of which Activa™ PC and Percept™ PC Neurostimulation Systems is the first listed.

NCT03900468 reports 13 study locations spanning 10 distinct geographic areas - top geographies include California, Ohio, Georgia.

Frequently Asked Questions

What is clinical trial NCT03900468 about?

NCT03900468 is a clinical study titled "Medtronic Deep Brain Stimulation (DBS) Therapy for Epilepsy Post-Approval Study (EPAS)". The purpose of this post-approval study is to further evaluate the long-term safety and effectiveness of Medtronic DBS therapy for epilepsy on seizure reduction in newly implanted participants through 3 years of follow-up.

What is the current status of trial NCT03900468?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 140 participants. The study started on 2020-03-05. Estimated completion is 2026-03-27.

What conditions does trial NCT03900468 study?

This clinical trial studies the following conditions: Epilepsy.

What interventions are being tested in trial NCT03900468?

The interventions under investigation include: Activa™ PC and Percept™ PC Neurostimulation Systems (DEVICE).

Who is sponsoring clinical trial NCT03900468?

This trial is sponsored by MedtronicNeuro, which has 51 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03900468 being conducted?

This trial has 13 study locations across California, Georgia, Illinois, Indiana, Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Epilepsy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Epilepsy

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.